Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2617)
All Articles published online
|
Jul 28, 2006 (publication date) through Nov 14, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Mousavi S, Toussy J, Yaghmaie S, Zahmatkesh M. Azithromycin in one week quadruple therapy for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i28/4553.htm |
| Number | Citing Articles |
| 1 |
Samin Alihosseini, Reza Ghotaslou, Fatemah Sadeghpour Heravi, Zainab Ahmadian, Hamed Ebrahimzadeh Leylabadlo. Management of antibiotic-resistantHelicobacter pyloriinfection: current perspective in Iran. Journal of Chemotherapy 2020; 32(6): 273 doi: 10.1080/1120009X.2020.1790889
|
| 2 |
Jie Dong, Xiao-Feng Yu, Jian Zou. Azithromycin-containing <italic>versus</italic> standard triple therapy for <italic>Helicobacter pylori</italic> eradication: A meta-analysis. World Journal of Gastroenterology 2009; 15(48): 6102-6110 doi: 10.3748/wjg.15.6102
|
| 3 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Mohammad Reza Naghipour, Atena Forouhari, Seyed Mohammad Seyed Saadat. Seven-day quintuple regimen as a rescue therapy for <italic>Helicobacter pylori</italic> eradication. World Journal of Gastroenterology 2015; 21(2): 661-666 doi: 10.3748/wjg.v21.i2.661
|
| 4 |
Mohammad Minakari, Amir Hosein Davarpanah Jazi, Ahmad Shavakhi, Neda Moghareabed, Farinaz Fatahi. A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second‐Line Therapy in Patients With Helicobacter pylori Infection. Helicobacter 2010; 15(2): 154 doi: 10.1111/j.1523-5378.2009.00739.x
|
| 5 |
Hafez Fakheri, Zohreh Bari, Mohsen Aarabi, Reza Malekzadeh. <italic>Helicobacter pylori</italic> eradication in West Asia: A review. World Journal of Gastroenterology 2014; 20(30): 10355-10367 doi: 10.3748/wjg.v20.i30.10355
|
| 6 |
Masoud Keikha, Parvin Askari, Kiarash Ghazvini, Mohsen Karbalaei. Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2022; 29: 420 doi: 10.1016/j.jgar.2021.10.019
|
| 7 |
Xue‐li Tian, Bao‐jun Suo, Hua Zhang, Hao‐ping Lu, Cai‐ling Li, Yu‐xin Zhang, Xin‐lu Ren, Xing‐yu Yao, Li‐ya Zhou, Zhi‐qiang Song. Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial. Helicobacter 2023; 28(1) doi: 10.1111/hel.12935
|
| 8 |
Hajarsadat Sadeghi, Tahmineh Narimani, Elham Tabesh, Fatemeh Shafiee, Rasool Soltani. Antibiotic resistance pattern of Helicobacter pylori strains isolated from patients in Isfahan, Iran. Journal of Research in Medical Sciences 2022; 27(1): 39 doi: 10.4103/jrms.jrms_829_21
|
| 9 |
Hafez Fakheri, Mehdi Saberi Firoozi, Zohreh Bari. Eradication of Helicobacter Pylori in Iran: A Review. Middle East Journal of Digestive Diseases 2017; 10(1): 5 doi: 10.15171/mejdd.2017.84
|